Share.

    1 Kommentar

    1. coinfeeds-bot on

      tldr; Biotech firm Windtree Therapeutics plans to purchase up to $700 million worth of BNB cryptocurrency after the asset hit an all-time high. The company is raising $520 million through equity lines and stock-purchase agreements to fund the acquisition, partnering with Kraken for custody. Windtree’s CEO emphasized the strategic importance of the move. BNB, launched by Binance, recently reached $808 before dipping. This aligns with a trend of companies building crypto treasuries, following pioneers like MicroStrategy.

      *This summary is auto generated by a bot and not meant to replace reading the original article. As always, DYOR.

    Leave A Reply